AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zunaglim MV 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Zunarsh Lifesciences Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Zunaglim MV 2mg/500mg/0.2mg Tablet

Diabetacrin 2mg/500mg/0.2mg tablets are classified as antidiabetic agents. This combined medication treats type 2 diabetes in adults, helping regulate blood glucose. Diabetacrin should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar; abrupt cessation, without consulting your doctor, risks elevated glucose levels and potential complications like kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions require physician consultation. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring, along with blood tests for cell counts and liver function, are typically recommended.

Uses of Zunaglim MV 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Zunaglim MV 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zunaglim MV 2mg/500mg/0.2mg Tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

Common Side effects of Zunaglim MV 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Zunaglim MV 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Zunaglim MV 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Consumption should occur on an empty stomach.

How Zunaglim MV 2mg/500mg/0.2mg Tablet works:

Each Zunaglim MV tablet (2mg/500mg/0.2mg) contains a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zunaglim MV 2mg/500mg/0.2mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Zunaglim MV 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Zunaglim MV 2mg/500mg/0.2mg Tablet while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.

KidneyKidneyUNSAFE

The use of Zunaglim MV 2mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Zunaglim MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should involve a reduced dosage; however, the medication is contraindicated in cases of severe liver disease.

What if you forget to take Zunaglim MV 2mg/500mg/0.2mg Tablet :

Should you forget a Zunaglim MV 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zunaglim MV 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zunaglim MV 2mg/500mg/0.2mg Tablet

Zunaglim MV 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Zunaglim MV 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Zunaglim MV 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Zunaglim MV 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Zunaglim MV 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Zunaglim MV 2mg/500mg/0.2...
105
MRP 122
13% off